ATM and pancreatic neoplasm: Several recent studies have assessed the prevalence of pathogenic germline variants in pancreatic cancer susceptibility genes and other hereditary cancer predisposition genes in patients with PDAC without or unselected for a family history and found that between 1.0–4.2% of patients have a pathogenic germline ATM variant (Table 1).